<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03243409</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-HUM-2017-51</org_study_id>
    <nct_id>NCT03243409</nct_id>
  </id_info>
  <brief_title>Perioperative Complications in Reversed Shoulder Arthroplasties</brief_title>
  <official_title>Perioperative Complications in Proximal Humeral Fractures Treated With Reversed Shoulder Arthroplasties</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective observational study of reversed shoulder arthroplasties by proximal humeral&#xD;
      fracture. Analysis of preoperative risk factors as well as minor and major complications at&#xD;
      the first week, 90 days and 1 year.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multicenter retrospective observational study (3 centers). Data are collected&#xD;
      from 105 patients over 65 years-old undergoing reversed shoulder arthroplasties by proximal&#xD;
      humerus fractures, in 3 or 4 parts.&#xD;
&#xD;
      Patient information is obtained from the clinical records in their usual preoperative&#xD;
      assessment, and follow-up on the usual routine checks, at the first week, 90 days and 1 year.&#xD;
&#xD;
      Minor and major complications rates are evaluated according to preoperative risk (ASA),&#xD;
      underlying diseases and according to anticoagulant / antiaggregant treatments.&#xD;
&#xD;
      Likewise, transfusion rates related to ASA, as well as length of hospital stay related to it.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 25, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients affected by minor complications after surgery, according to underlying disease</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiovascular diseases affected by minor complications after surgery</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiovascular diseases affected by minor complications after surgery</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiovascular diseases affected by major complications after surgery</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiovascular diseases affected by major complications after surgery</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiovascular diseases affected by major complications after surgery</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing anticoagulant treatment with minor complications</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Previous acenocoumarol treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing anticoagulant treatment with major complications</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Previous acenocoumarol treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing anticoagulant treatment with minor complications</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Previous acenocoumarol treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing anticoagulant treatment with major complications</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Previous acenocoumarol treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing antiplatelet treatment with minor complications</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing antiplatelet treatment with major complications</measure>
    <time_frame>First week after surgery</time_frame>
    <description>Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing antiplatelet treatment with minor complications</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients undergoing antiplatelet treatment with major complications</measure>
    <time_frame>90 days after surgery</time_frame>
    <description>Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion rates according to the preoperative ASA group</measure>
    <time_frame>1 week after surgery</time_frame>
    <description>Number of transfusion requirement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay according to the preoperative ASA group</measure>
    <time_frame>1 week after surgery</time_frame>
    <description>Length from the surgical intervention according to ASA risk</description>
  </secondary_outcome>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Proximal Humeral Fracture</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing reversed shoulder arthroplasties owing to three or four parts fractures&#xD;
        of the proximal humerus&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Complex( 3- or 4-part) humerus fractures undergoing reversed shoulder arthroplasties.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No exclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Carles Torrens Canovas</last_name>
    <role>Study Director</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Noguera Alonso</last_name>
    <phone>+34660708399</phone>
    <email>lnoguera@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Noguera, MD</last_name>
      <email>lnoguera@santpau.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Ferrel JR, Trinh TQ, Fischer RA. Reverse total shoulder arthroplasty versus hemiarthroplasty for proximal humeral fractures: a systematic review. J Orthop Trauma. 2015 Jan;29(1):60-8. doi: 10.1097/BOT.0000000000000224.</citation>
    <PMID>25186842</PMID>
  </reference>
  <reference>
    <citation>Boileau P, Winter M, Cikes A, Han Y, Carles M, Walch G, Schwartz DG. Can surgeons predict what makes a good hemiarthroplasty for fracture? J Shoulder Elbow Surg. 2013 Nov;22(11):1495-506. doi: 10.1016/j.jse.2013.04.018. Epub 2013 Jul 5.</citation>
    <PMID>23834993</PMID>
  </reference>
  <reference>
    <citation>Bufquin T, Hersan A, Hubert L, Massin P. Reverse shoulder arthroplasty for the treatment of three- and four-part fractures of the proximal humerus in the elderly: a prospective review of 43 cases with a short-term follow-up. J Bone Joint Surg Br. 2007 Apr;89(4):516-20. doi: 10.1302/0301-620X.89B4.18435.</citation>
    <PMID>17463122</PMID>
  </reference>
  <reference>
    <citation>Stanbury SJ, Voloshin I. Reverse shoulder arthroplasty for acute proximal humeral fractures in the geriatric patient: a review of the literature. Geriatr Orthop Surg Rehabil. 2011 Sep;2(5-6):181-6. doi: 10.1177/2151458511420140.</citation>
    <PMID>23569688</PMID>
  </reference>
  <reference>
    <citation>Cuff DJ, Pupello DR. Comparison of hemiarthroplasty and reverse shoulder arthroplasty for the treatment of proximal humeral fractures in elderly patients. J Bone Joint Surg Am. 2013 Nov 20;95(22):2050-5. doi: 10.2106/JBJS.L.01637.</citation>
    <PMID>24257664</PMID>
  </reference>
  <reference>
    <citation>Boyle MJ, Youn SM, Frampton CM, Ball CM. Functional outcomes of reverse shoulder arthroplasty compared with hemiarthroplasty for acute proximal humeral fractures. J Shoulder Elbow Surg. 2013 Jan;22(1):32-7. doi: 10.1016/j.jse.2012.03.006. Epub 2012 May 29.</citation>
    <PMID>22652065</PMID>
  </reference>
  <reference>
    <citation>Jones KJ, Dines DM, Gulotta L, Dines JS. Management of proximal humerus fractures utilizing reverse total shoulder arthroplasty. Curr Rev Musculoskelet Med. 2013 Mar;6(1):63-70. doi: 10.1007/s12178-013-9155-1.</citation>
    <PMID>23334846</PMID>
  </reference>
  <reference>
    <citation>Lenarz C, Shishani Y, McCrum C, Nowinski RJ, Edwards TB, Gobezie R. Is reverse shoulder arthroplasty appropriate for the treatment of fractures in the older patient? Early observations. Clin Orthop Relat Res. 2011 Dec;469(12):3324-31. doi: 10.1007/s11999-011-2055-z.</citation>
    <PMID>21879403</PMID>
  </reference>
  <reference>
    <citation>Chalmers PN, Slikker W 3rd, Mall NA, Gupta AK, Rahman Z, Enriquez D, Nicholson GP. Author reply: reverse total shoulder for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty. J Shoulder Elbow Surg. 2014 Sep;23(9):e222. doi: 10.1016/j.jse.2014.05.014. Epub 2014 Jul 24. No abstract available.</citation>
    <PMID>25066822</PMID>
  </reference>
  <reference>
    <citation>Acevedo DC, Vanbeek C, Lazarus MD, Williams GR, Abboud JA. Reverse shoulder arthroplasty for proximal humeral fractures: update on indications, technique, and results. J Shoulder Elbow Surg. 2014 Feb;23(2):279-89. doi: 10.1016/j.jse.2013.10.003.</citation>
    <PMID>24418780</PMID>
  </reference>
  <reference>
    <citation>Mata-Fink A, Meinke M, Jones C, Kim B, Bell JE. Reverse shoulder arthroplasty for treatment of proximal humeral fractures in older adults: a systematic review. J Shoulder Elbow Surg. 2013 Dec;22(12):1737-48. doi: 10.1016/j.jse.2013.08.021.</citation>
    <PMID>24246529</PMID>
  </reference>
  <reference>
    <citation>Sebastia-Forcada E, Cebrian-Gomez R, Lizaur-Utrilla A, Gil-Guillen V. Reverse shoulder arthroplasty versus hemiarthroplasty for acute proximal humeral fractures. A blinded, randomized, controlled, prospective study. J Shoulder Elbow Surg. 2014 Oct;23(10):1419-26. doi: 10.1016/j.jse.2014.06.035. Epub 2014 Jul 30.</citation>
    <PMID>25086490</PMID>
  </reference>
  <reference>
    <citation>Wall B, Walch G. Reverse shoulder arthroplasty for the treatment of proximal humeral fractures. Hand Clin. 2007 Nov;23(4):425-30, v-vi. doi: 10.1016/j.hcl.2007.08.002.</citation>
    <PMID>18054669</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>July 31, 2017</study_first_submitted>
  <study_first_submitted_qc>August 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2017</study_first_posted>
  <last_update_submitted>August 3, 2017</last_update_submitted>
  <last_update_submitted_qc>August 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>reversed shoulder arthroplasties</keyword>
  <keyword>clinical complications</keyword>
  <keyword>complex proximal humeral fractures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03243409
org study id: IIBSP-HUM-2017-51
nct id: NCT03243409
lead sponsor: 
has dmc: Yes
is fda regulated drug: No
is fda regulated device: No
Retrospective observational study of reversed shoulder arthroplasties by proximal humeral
      fracture. Analysis of preoperative risk factors as well as minor and major complications at
      the first week, 90 days and 1 year.
The study is a multicenter retrospective observational study (3 centers). Data are collected
      from 105 patients over 65 years-old undergoing reversed shoulder arthroplasties by proximal
      humerus fractures, in 3 or 4 parts.

      Patient information is obtained from the clinical records in their usual preoperative
      assessment, and follow-up on the usual routine checks, at the first week, 90 days and 1 year.

      Minor and major complications rates are evaluated according to preoperative risk (ASA),
      underlying diseases and according to anticoagulant / antiaggregant treatments.

      Likewise, transfusion rates related to ASA, as well as length of hospital stay related to it.
observational model: Case-Only
time perspective: Retrospective
measure: Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.
time frame: First week after surgery
description: Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties
measure: Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.
time frame: 90 days after surgery
description: Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties
measure: Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.
time frame: 1 year after surgery
description: Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties
measure: Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.
time frame: First week after surgery
description: Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery
measure: Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.
time frame: 90 days after surgery
description: Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery
measure: Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.
time frame: 1 year after surgery
description: Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery
measure: Number of patients affected by minor complications after surgery, according to underlying disease
time frame: First week after surgery
description: Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.
measure: Number of patients with cardiovascular diseases affected by minor complications after surgery
time frame: 90 days after surgery
description: Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.
measure: Number of patients with cardiovascular diseases affected by minor complications after surgery
time frame: 1 year after surgery
description: Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.
measure: Number of patients with cardiovascular diseases affected by major complications after surgery
time frame: First week after surgery
description: Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.
measure: Number of patients with cardiovascular diseases affected by major complications after surgery
time frame: 90 days after surgery
description: Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.
measure: Number of patients with cardiovascular diseases affected by major complications after surgery
time frame: 1 year after surgery
description: Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.
measure: Number of patients undergoing anticoagulant treatment with minor complications
time frame: First week after surgery
description: Previous acenocoumarol treatment
measure: Number of patients undergoing anticoagulant treatment with major complications
time frame: First week after surgery
description: Previous acenocoumarol treatment
measure: Number of patients undergoing anticoagulant treatment with minor complications
time frame: 90 days after surgery
description: Previous acenocoumarol treatment
measure: Number of patients undergoing anticoagulant treatment with major complications
time frame: 90 days after surgery
description: Previous acenocoumarol treatment
measure: Number of patients undergoing antiplatelet treatment with minor complications
time frame: First week after surgery
description: Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel
measure: Number of patients undergoing antiplatelet treatment with major complications
time frame: First week after surgery
description: Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel
measure: Number of patients undergoing antiplatelet treatment with minor complications
time frame: 90 days after surgery
description: Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel
measure: Number of patients undergoing antiplatelet treatment with major complications
time frame: 90 days after surgery
description: Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel
measure: Transfusion rates according to the preoperative ASA group
time frame: 1 week after surgery
description: Number of transfusion requirement.
measure: Length of hospital stay according to the preoperative ASA group
time frame: 1 week after surgery
description: Length from the surgical intervention according to ASA risk
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: 65 Years
maximum age: N/A
last name: Carles Torrens Canovas
role: Study Director
affiliation: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
last name: Laura Noguera Alonso
phone: +34660708399
email: lnoguera@santpau.cat
facility: 
status: Recruiting
contact: 
country: Spain
citation: Ferrel JR, Trinh TQ, Fischer RA. Reverse total shoulder arthroplasty versus hemiarthroplasty for proximal humeral fractures: a systematic review. J Orthop Trauma. 2015 Jan;29(1):60-8. doi: 10.1097/BOT.0000000000000224.
PMID: 25186842
citation: Boileau P, Winter M, Cikes A, Han Y, Carles M, Walch G, Schwartz DG. Can surgeons predict what makes a good hemiarthroplasty for fracture? J Shoulder Elbow Surg. 2013 Nov;22(11):1495-506. doi: 10.1016/j.jse.2013.04.018. Epub 2013 Jul 5.
PMID: 23834993
citation: Bufquin T, Hersan A, Hubert L, Massin P. Reverse shoulder arthroplasty for the treatment of three- and four-part fractures of the proximal humerus in the elderly: a prospective review of 43 cases with a short-term follow-up. J Bone Joint Surg Br. 2007 Apr;89(4):516-20. doi: 10.1302/0301-620X.89B4.18435.
PMID: 17463122
citation: Stanbury SJ, Voloshin I. Reverse shoulder arthroplasty for acute proximal humeral fractures in the geriatric patient: a review of the literature. Geriatr Orthop Surg Rehabil. 2011 Sep;2(5-6):181-6. doi: 10.1177/2151458511420140.
PMID: 23569688
citation: Cuff DJ, Pupello DR. Comparison of hemiarthroplasty and reverse shoulder arthroplasty for the treatment of proximal humeral fractures in elderly patients. J Bone Joint Surg Am. 2013 Nov 20;95(22):2050-5. doi: 10.2106/JBJS.L.01637.
PMID: 24257664
citation: Boyle MJ, Youn SM, Frampton CM, Ball CM. Functional outcomes of reverse shoulder arthroplasty compared with hemiarthroplasty for acute proximal humeral fractures. J Shoulder Elbow Surg. 2013 Jan;22(1):32-7. doi: 10.1016/j.jse.2012.03.006. Epub 2012 May 29.
PMID: 22652065
citation: Jones KJ, Dines DM, Gulotta L, Dines JS. Management of proximal humerus fractures utilizing reverse total shoulder arthroplasty. Curr Rev Musculoskelet Med. 2013 Mar;6(1):63-70. doi: 10.1007/s12178-013-9155-1.
PMID: 23334846
citation: Lenarz C, Shishani Y, McCrum C, Nowinski RJ, Edwards TB, Gobezie R. Is reverse shoulder arthroplasty appropriate for the treatment of fractures in the older patient? Early observations. Clin Orthop Relat Res. 2011 Dec;469(12):3324-31. doi: 10.1007/s11999-011-2055-z.
PMID: 21879403
citation: Chalmers PN, Slikker W 3rd, Mall NA, Gupta AK, Rahman Z, Enriquez D, Nicholson GP. Author reply: reverse total shoulder for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty. J Shoulder Elbow Surg. 2014 Sep;23(9):e222. doi: 10.1016/j.jse.2014.05.014. Epub 2014 Jul 24. No abstract available.
PMID: 25066822
citation: Acevedo DC, Vanbeek C, Lazarus MD, Williams GR, Abboud JA. Reverse shoulder arthroplasty for proximal humeral fractures: update on indications, technique, and results. J Shoulder Elbow Surg. 2014 Feb;23(2):279-89. doi: 10.1016/j.jse.2013.10.003.
PMID: 24418780
citation: Mata-Fink A, Meinke M, Jones C, Kim B, Bell JE. Reverse shoulder arthroplasty for treatment of proximal humeral fractures in older adults: a systematic review. J Shoulder Elbow Surg. 2013 Dec;22(12):1737-48. doi: 10.1016/j.jse.2013.08.021.
PMID: 24246529
citation: Sebastia-Forcada E, Cebrian-Gomez R, Lizaur-Utrilla A, Gil-Guillen V. Reverse shoulder arthroplasty versus hemiarthroplasty for acute proximal humeral fractures. A blinded, randomized, controlled, prospective study. J Shoulder Elbow Surg. 2014 Oct;23(10):1419-26. doi: 10.1016/j.jse.2014.06.035. Epub 2014 Jul 30.
PMID: 25086490
citation: Wall B, Walch G. Reverse shoulder arthroplasty for the treatment of proximal humeral fractures. Hand Clin. 2007 Nov;23(4):425-30, v-vi. doi: 10.1016/j.hcl.2007.08.002.
PMID: 18054669
responsible party type: Sponsor
mesh term: Fractures, Bone
mesh term: Humeral Fractures
mesh term: Shoulder Fractures
sharing ipd: No